GHK-Cu / Exosome Cream 10/.01MG

GHK-Cu Exosome Cream — Research Overview

GHK-Cu Exosome Cream is an advanced research formulation combining two distinct biological research agents in a single topical delivery system: GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) at 10mg and exosomes at 0.01mg per unit.

What Makes This Format Different

Standard GHK-Cu cream delivers the copper peptide to dermal tissue through topical absorption. This formulation adds exosomes, nano-sized extracellular vesicles secreted by cells that serve as natural carriers of proteins, lipids, and nucleic acids between cells. In research contexts, exosomes are studied as mediators of intercellular communication that can influence gene expression and cellular behavior in recipient cells.

The research rationale for combining GHK-Cu with exosomes is mechanistic complementarity. GHK-Cu modulates gene expression and collagen synthesis directly through copper-dependent enzyme pathways and receptor-independent signaling. Exosomes carry cargo that can alter cellular behavior through a parallel intercellular communication pathway. Research examining both mechanisms together allows scientists to study whether the two approaches produce additive or synergistic effects in dermal tissue models.

Exosome Research Context

Exosome research has grown significantly since the early 2010s. Studies have documented exosome involvement in wound healing, inflammatory modulation, and tissue regeneration across multiple tissue types. In dermal research models, exosomes derived from various cell sources have been shown to influence fibroblast behavior, keratinocyte migration, and collagen production. This area of research is earlier stage than the GHK-Cu literature but is growing rapidly.

GHK-Cu Research Background

GHK-Cu has over 50 years of published research behind it. The most relevant findings for dermal research include stimulation of collagen and glycosaminoglycan synthesis, modulation of matrix metalloproteinase activity, and gene expression effects across over 4,000 human genes documented in the 2018 Pickart and Margolina review (DOI: 10.3390/ijms19071987). A 2023 double-blind clinical study confirmed measurable collagen upregulation at the tissue level in human skin biopsies following 12 weeks of GHK-Cu topical application.

Full GHK-Cu research overview with citations →

This product is sold for laboratory research purposes only. Nothing on this page constitutes medical advice. Not intended for human therapeutic use.